However, except for rare cases with Bcl-2 amplification, pathological mutations are rarely observed in the Bcl-2 gene in these cases, whereas translocations or somatic mutations are frequently observed in de novo DLBCL [11]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.